These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26581001)

  • 21. Hereditary non-medullary thyroid cancer.
    Kebebew E
    World J Surg; 2008 May; 32(5):678-82. PubMed ID: 18058169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hereditary thyroid carcinoma and its molecular diagnostics].
    Dvořáková S; Václavíková E; Sýkorová V; Hálková T; Bendlová B
    Cesk Patol; 2014 Apr; 50(2):81-6. PubMed ID: 24758503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The G534E variant in HABP2 is not associated with increased risk of familial nonmedullary thyroid cancer in Brazilian Kindreds.
    de Mello LEB; Araujo AN; Alves CX; de Paiva FJP; Brandão-Neto J; Cerutti JM
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):113-114. PubMed ID: 28418605
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylactic thyroidectomy: who needs it, when, and why.
    Wang TS; Opoku-Boateng A; Roman SA; Sosa JA
    J Surg Oncol; 2015 Jan; 111(1):61-5. PubMed ID: 24965542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid cancer of follicular cell origin in inherited tumor syndromes.
    Nosé V
    Adv Anat Pathol; 2010 Nov; 17(6):428-36. PubMed ID: 20966648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid adenoma and nonmedullary thyroid carcinoma association.
    Simpson RJ; Moss J
    Otolaryngol Head Neck Surg; 1989 Nov; 101(5):584-7. PubMed ID: 2574436
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The thyrotropin receptor in thyroid diseases.
    Paschke R; Ludgate M
    N Engl J Med; 1997 Dec; 337(23):1675-81. PubMed ID: 9385128
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic impact of germline mutations in inherited cancer syndromes.
    Corso G; Feroce I; Intra M; Veronesi P; Sacchini V; Bonanni B; Galimberti V
    Future Oncol; 2017 Oct; 13(24):2125-2127. PubMed ID: 28984488
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.
    Vernez M; Hutter P; Monnerat C; Halkic N; Gugerli O; Bouzourene H
    Fam Cancer; 2007; 6(1):141-5. PubMed ID: 17051350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pitfalls of Personalizing Cancer Treatment.
    Perez K
    Am J Clin Oncol; 2016 Feb; 39(1):107. PubMed ID: 26785382
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.
    Borrello MG; Aiello A; Peissel B; Rizzetti MG; Mondellini P; Degl'Innocenti D; Catalano V; Gobbo M; Collini P; Bongarzone I; Pierotti MA; Greco A; Seregni E
    Endocr Relat Cancer; 2011 Aug; 18(4):519-27. PubMed ID: 21690267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.
    Xing M
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):263-6. PubMed ID: 16117812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial thyroid neoplasia: impact of technological advances on detection and monitoring.
    Tran T; Gianoukakis AG
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):425-31. PubMed ID: 20729730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of patients with hereditary gastrointestinal cancer syndromes.
    Moreira L; Castells A
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):923-935. PubMed ID: 27938787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
    Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very early manifestation of hereditary medullary thyroid cancer in carriers of intracellular-domain RET mutations.
    Machens A; Dralle H
    J Pediatr Surg; 2007 Jun; 42(6):1153; author reply 1154. PubMed ID: 17560241
    [No Abstract]   [Full Text] [Related]  

  • 38. Mendelian genetics of rare--and not so rare--cancers.
    Eng C
    Ann N Y Acad Sci; 2010 Dec; 1214():70-82. PubMed ID: 20946573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1.
    Bevan S; Pal T; Greenberg CR; Green H; Wixey J; Bignell G; Narod SA; Foulkes WD; Stratton MR; Houlston RS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3701-4. PubMed ID: 11502798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2.
    Harach HR; Lesueur F; Amati P; Brown A; Canzian F; Kraimps JL; Levillain P; Menet E; Romeo G; Bonneau D
    J Pathol; 1999 Nov; 189(3):387-93. PubMed ID: 10547601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.